Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14286-03-4

Post Buying Request

14286-03-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14286-03-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 14286-03-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,2,8 and 6 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 14286-03:
(7*1)+(6*4)+(5*2)+(4*8)+(3*6)+(2*0)+(1*3)=94
94 % 10 = 4
So 14286-03-4 is a valid CAS Registry Number.

14286-03-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name DIAMMINEDINITROPLATINUM(II)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14286-03-4 SDS

14286-03-4Relevant articles and documents

King, H. J. S.

, (1938)

A novel platinum-based liposome preparation, and its preparation method

-

Paragraph 0061; 0062, (2017/02/24)

The invention relates to a novel platinum compound, a liposome preparation containing the compound, a preparation method of the liposome preparation and an application of the liposome preparation in tumor treatment. The main components of the platinum liposome provided by the invention include active platinum compounds, phospholipid, cholesterol, fatty acid and the like, the platinum liposome can be prepared into a freeze-dried powder injection by freeze drying, and the platinum liposome is small in particle size, high in medicine loading capacity and good in stability. The platinum liposome can improve the bioavailability of cisplatin liposome, prolong the residence time of the medicine in vivo and concentrate the cisplatin in cancerous organs, thereby not only reducing the medicine dosage and reinforcing the curative effect, but also capable of reducing the toxic side effects of the medicine, so that the platinum liposome is suitable for treating a variety of tumor diseases.

CARRIER THAT TARGETS FUCOSYLATED MOLECULE-PRODUCING CELLS

-

Paragraph 0139, (2015/02/18)

The present invention relates to a carrier that is targeted at fucosylated molecule-producing cells, which comprises an effective amount of fucose for targeting said cells, to a composition comprising the carrier, and to a method for treating and diagnosing a disease related to fucosylated molecule-producing cells utilizing said carrier, etc. The carrier of the present invention enables to deliver a substance specifically to fucosylated molecule-producing cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14286-03-4